Responses
Regular and Young Investigator Award Abstracts
Immuno-Conjugates and Chimeric Molecules
1200 Leveraging the immunocompetent Vk*MYChCRBN model of multiple myeloma to determine and overcome T cell engager antibody resistance mechanisms
Compose a Response to This Article
Other responses
No responses have been published for this article.
